Weight loss drugs make it harder to get the nutrients you need – here’s what to do about it
Weight-loss drugs such as Ozempic, Wegovy and Mounjaro work primarily by reducing hunger. They mimic a hormone the body already produces called glucagon-like peptide-1 (GLP-1), which helps regulate appetite and feelings of fullness. By slowing how quickly food leaves the stomach and acting on appetite centres in the brain, the drugs help people feel full […]
GLP-1 Drugs May Protect Against Vertebral Fractures
Glucagon-like peptide-1 (GLP-1) receptor agonists were associated with a lower vertebral fracture risk in patients with type 2 diabetes, according to a study published in JAMA Surgery.
6 Takeaways from the WHO’s First Obesity Drug Guideline
This Medical News article discusses key learnings from new World Health Organization guidance on the use of glucagon-like peptide-1 (GLP-1) medications for the treatment of obesity in adults.
Weight Often Returns After Stopping Ozempic, Wegovy, Study Finds
FRIDAY, Jan. 9, 2026 — People who stop taking popular weight loss drugs like Ozempic and Wegovy are likely to gain the weight back, and sooner than many expect, a new study finds.
Researchers reviewed dozens of earlier studies and found that…
Nutritional Guidance Lacking for Adults Receiving Semaglutide, Tirzepatide
FRIDAY, Jan. 9, 2026 — Nutritional guidance to support safe weight loss is frequently lacking for adults with obesity or type 2 diabetes receiving semaglutide or tirzepatide, according to a study published online Jan. 8 in Obesity Reviews.
Marie…
The Simply Good Foods Company (NASDAQ:SMPL) Q1 2026 Earnings Call Transcript
The Simply Good Foods Company (NASDAQ:SMPL) Q1 2026 Earnings Call Transcript January 8, 2026 The Simply Good Foods Company beats earnings expectations. Reported EPS is $0.39, expectations were $0.36. Operator: Greetings. Welcome to Simply Good Foods Company’s First Quarter Fiscal Year 2026 Earnings Call. [Operator Instructions] Please note, this conference is being recorded. At this […]
Prescryptive and Ilant Health Expand Employer-Direct Access to Obesity Care and Transparent GLP-1 Access at Scale
REDMOND, Wash., Jan. 9, 2026 /PRNewswire/ — Prescryptive and Ilant Health today announced a collaboration to help employers access transparent GLP-1 pricing alongside expert, outcomes-driven clinical care. The collaboration runs on Prescryptive’s direct-to-market platform, aligned by…
The 10 Things RDs Want You to Know About Shopping Greens Powders
Chances are, you’ve heard about greens powders, maybe from a podcast, a friend, or a social media post. They’re everywhere, promising benefits from a quick boost in energy to better gut health and immunity…all in a single scoop. It’s no surprise they’ve become a go-to for influencers, coaches, and wellness enthusiasts alike. If you’ve ever […]
Amazon Pharmacy Expands Access to New Wegovy® Pill with Insurance and Cash-Pay Options
SEATTLE–(BUSINESS WIRE)–Amazon Pharmacy now offers Novo Nordisk’s newly FDA-approved oral GLP-1 with transparent pricing and fast, free home delivery
Weight-loss experts predict 5 major treatment changes likely to emerge in 2026
Big moves are continuing in the weight loss landscape in the new year following breakthrough research of GLP-1 medications and other methods. Weight-loss experts spoke with Fox News Digital about their predictions for the most major changes to come in 2026. Dr. Peter Balazs, a hormone and weight loss specialist in New York and New […]